Published in
Springer, Investigational New Drugs, 1(24), p. 89-94, 2006
DOI: 10.1007/s10637-005-4544-y
Links
Tools
A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma
Journal article published in 2006 by
Karl D. Lewis,
John A. Thompson,
Jeffrey S. Weber,
William A. Robinson,
Steven O'Day,
Jose Lutzky 
,
Sewa S. Legha,
Simon Floret,
Francis Ruvuna,
Rene Gonzalez
,
Sewa S. Legha,
Simon Floret,
Francis Ruvuna,
Rene Gonzalez
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 